-
Biocon Limited signs an exclusive licensing and supply agreement for generic
Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A.
20 Apr 2024 09:27 GMT
… the terms of this agreement, Biocon will undertake the development, manufacturing … developing, manufacturing and commercializing complex biotech and biosimilar drug products at … Executive Officer and Managing Director, Biocon Ltd, said, “Our partnership …
-
Biocon Ltd signs an exclusive licensing and supply agreement for generic Ozempic commercialization in Brazil with Biomm S.A.
19 Apr 2024 18:09 GMT
… the terms of this agreement, Biocon will undertake the development, … , manufacturing and commercializing complex biotech and biosimilar drug products at … .
Source : Equity Bulls
Keywords
Biocon
INE376G01013
ExclusiveAgreement
Licensing
Supply
Ozempic …
-
Biocon Inks Agreement with Biomm SA to Distribute Diabetes Medication in Brazil
18 Apr 2024 13:51 GMT
Biocon entered into an exclusive … Brazil, enabling Biomm to commercialize Biocon’s drug Semaglutide (marketed … 2 diabetes in adults. Biocon will handle the development, … manufacturing, and commercialization of complex biotech and biosimilar drug products at …
-
Biocon partners Biomm to commercialise diabetes drug in Brazil
17 Apr 2024 15:28 GMT
Biotechnology firm Biocon on Wednesday said it … terms of the agreement, Biocon will undertake the development, … , manufacturing and commercialising complex biotech and biosimilar drug products at … Europe for Peptides," Biocon CEO and MD Siddharth Mittal …
-
Latest News | Biocon Partners Biomm to Commercialise Diabetes Drug in Brazil
17 Apr 2024 14:46 GMT
… Apr 17 (PTI) Biotechnology firm Biocon on Wednesday said it … terms of the agreement, Biocon will undertake the development, … manufacturing and commercialising complex biotech and biosimilar drug products … Europe for Peptides," Biocon CEO and MD Siddharth …
-
STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more
08 Apr 2024 18:03 GMT
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because the usual routine of online meetings, phone calls, and deadlines has inevitably returned. But you knew this would happen, yes? …
-
Happy Birthday Kiran Mazumdar Shaw: Learn the biotech billionaire’s rules for success in business
23 Mar 2024 05:24 GMT
… pioneer of India's biotech industry having founded one of … : X/ @kiranshaw)
New Delhi: Biocon founder Kiran Mazumdar Shaw, who … years old today, started biotech firm Biocon from her garage in 1978 … and became India’s first biotech company to clock $ 1 …
-
'Please do the math': Biocon boss Kiran Mazumdar-Shaw schools X user on electoral bonds
16 Mar 2024 05:56 GMT
… the uproar over electoral bonds, Biocon Executive Chairperson Kiran Mazumdar-Shaw … ), USV, Intas; vaccine companies Bharat Biotech and Chiron Behring, and Biological …
-
Why Biocon boss Kiran Mazumdar-Shaw is seeing red over Pink Tax
13 Mar 2024 15:13 GMT
Biocon boss Kiran Mazumdar-Shaw on … Tax'.
"Hope your biotech products don't subscribe …
-
Biocon Biologics gets Canada market entry date for ophthalmic drug Yesafili
04 Mar 2024 04:56 GMT
… 2025, the subsidiary of biotechnology major Biocon said on March 4 … and a subsidiary of Biocon Ltd, has announced the … up new avenues for Biocon Biologics. Yesafili is a … trademark of Biocon Biologics.
Following the announcement, Biocon Biologics shares …